Valuation: DocMorris AG

Market Cap 540M 651M 573M 492M 921M 62.48B 928M 6.48B 2.51B 31.8B 2.44B 2.39B 103B P/E 2026 *
-6.62x
P/E 2027 * -15.2x
Enterprise Value 742M 895M 787M 677M 1.27B 85.9B 1.28B 8.9B 3.45B 43.72B 3.36B 3.29B 142B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.55x
Free-Float
62.21%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 669M
-0.50%+4.37%-46.73%-14.05% 14.63B
-0.16%+1.14%-16.47%-4.85% 6.28B
-0.35%-3.09%-56.54%-39.77% 5.84B
-0.05%-2.34%-10.02%-24.30% 3.99B
+0.33%+0.66%-18.64%-37.19% 3.16B
+0.28%+11.62%-40.91%-17.44% 3.02B
-2.34%-3.68%+2.57%-30.99% 3.05B
-3.40%-10.17%+62.86% - 2.74B
+0.74%-4.12%-24.55%-14.49% 2.28B
Average -0.54%-1.00%-16.49%-22.88% 5B
Weighted average by Cap. -0.51%+0.67%-27.02%-20.42%

Financials

2026 *2027 *
Net sales 1.26B 1.52B 1.34B 1.15B 2.15B 146B 2.17B 15.14B 5.87B 74.32B 5.71B 5.59B 242B 1.41B 1.69B 1.49B 1.28B 2.4B 163B 2.42B 16.86B 6.53B 82.79B 6.36B 6.22B 269B
Net income -85.9M -104M -91.13M -78.38M -147M -9.94B -148M -1.03B -399M -5.06B -389M -381M -16.47B -38.94M -46.96M -41.31M -35.53M -66.44M -4.51B -66.95M -467M -181M -2.29B -176M -172M -7.47B
Net Debt 202M 244M 215M 185M 345M 23.42B 348M 2.43B 941M 11.92B 916M 896M 38.79B 232M 280M 246M 212M 396M 26.87B 399M 2.79B 1.08B 13.68B 1.05B 1.03B 44.51B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
10.69CHF
Average target price
11.29CHF
Spread / Average Target
+5.65%

Quarterly revenue - Rate of surprise